Drug intelligence / Profile preview

astaxanthin + ubiquinol

Development stage
Unknown
Lead developer
Gynogen
Modality
Small Molecules
Administration
Oral
01

Overview

Astaxanthin + ubiquinol is an oral combination nutraceutical formulation containing the carotenoid antioxidant astaxanthin and the reduced, active form of Coenzyme Q10, ubiquinol. Developed and distributed by companies such as Gynogen, this combination is designed to mitigate oxidative stress and support cellular energy production. Astaxanthin acts as a potent quencher of singlet oxygen and free radicals, protecting lipid membranes from peroxidation. Ubiquinol serves as a critical component of the mitochondrial electron transport chain, facilitating ATP synthesis and providing lipid-soluble antioxidant protection. The combination is primarily used to support cardiovascular, neurological, and reproductive health, particularly in the management of male infertility and age-related oxidative damage.

Other names
astaxanthin + reduced coenzyme q10astaxanthin + ubiquinolastaxanthin + reduced CoQ10
02

Targets

OXPHOS (Mitochondrial OXPHOS complexes)

Beyond the preview

Go deeper on astaxanthin + ubiquinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on astaxanthin + ubiquinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call